DUBLIN--(BUSINESS WIRE)--The "Female Contraception - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.
Female Contraception - Pipeline Review, H1 2018 provides comprehensive information on the therapeutics under development for Female Contraception (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Female Contraception (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities/Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 5, 3, 8 and 4 respectively. Similarly, the Universities portfolio in Pre-Registration, Phase II and Preclinical stages comprises 1, 1 and 2 molecules, respectively.
Female Contraception (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Introduction
- Report Coverage
- Female Contraception - Overview
- Female Contraception - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Female Contraception - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Female Contraception - Companies Involved in Therapeutics Development
- Agile Therapeutics Inc
- Bayer AG
- Evofem Biosciences Inc
- Hervana Ltd
- MedinCell SA
- Mithra Pharmaceuticals SA
- Orbis Biosciences Inc
- Teva Pharmaceutical Industries Ltd
- Viramal Ltd
For more information about this report visit https://www.researchandmarkets.com/research/2g8mqv/female?w=4
